IndexCopernicus™ Authors Information
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
Michael F X Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, Stephan Grampp, Helmut Kaessmann, Marianne Schmid, Christian Menzel, Jutta Claudia Piswanger-Soelkner, Arik Galid, Martina Mittlboeck, Hubert Hausmaninger, Raimund Jakesz, Raimund Jakesz
J Clin Oncol 2007; 25(7):820-828
ICID: 494972
IC™ Value: 1.20
Author's profile available for:
  • Michael F X Gnant - click here